Skip to content
What we do
Close What we do
Open What we do
Strategic service solutions
Strategic consulting
Medical communications
Commercialization
Revenue management and market access
AI and technology solutions
EnvisionOne
iEnvision
EnvisionOne Insights & Analytics
EPG AI
Riparian technology
About
News and views
Careers
Close Careers
Open Careers
Life at Envision
Benefits at Envision
Open opportunities
FAQs
Meet the talent team
Contact
MENU
MENU
Home
What we do
About
News and views
Careers
Contact
Search
Search
News and
views
Exploring news, ideas,
innovations, and
impact
Mar. 02, 2026
Featured
Reimagining patient engagement as a strategic advantage
Medical
,
Patient Engagement
,
Publications
Why early, ongoing patient involvement is the future of smarter clinical development
Learn More
Latest news
Case study
Company news
Employee news
Industry insights
Thought leadership
Uncategorized
All
New
Paul Archer promoted to Chief Commercial Strategy Officer
Executive Leadership
Feb. 18, 2022
Learn More
Share
GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth
GHO
,
Medical
,
Riparian
,
Strategic Consulting
,
Technology
,
Two Labs
Nov. 21, 2021
Learn more
Two Labs, an Envision Pharma Group company acquires Riparian
Market Access
,
Pricing
,
Revenue Management
,
Riparian
,
Technology
,
Two Labs
Jul. 17, 2021
Learn more
Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering
Commercialization
,
Compliance
,
Launch
,
Market Access
,
Strategic Consulting
,
Two Labs
Nov. 12, 2020
Learn more
90TEN acquired by Envision Pharma Group
Medical
,
Patient Engagement
,
PR
,
Strategic Consulting
Apr. 08, 2020
Learn more
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
The Envision newsletter
The latest news and thought leadership from Envision Pharma Group, delivered straight to your inbox.
